The common autosomal dominant form of hereditary spherocytosis (HS) has been genetically linked to defects of the erythroid ankyrin gene in a few families; however, the frequency of ankyrin deficiency and its relationship to red blood cell (RBC) spectrin content are unknown. To test these questions, we measured RBC spectrin and ankyrin by radioimmunoassay in 39 patients from 20 families with dominant HS. Normal RBCs contained 242,000 f 20,500 spectrin heterodimers and 124,500 f 1 1,000 ankyrins per cell. In dominant HS, RBC spectrin and ankyrin ranged from about 40% to 100% of normal and were continuously distributed. Measurements in the same patient on different occasions were reproducible ( f 5% to 10%) and RBCs from affected members of a kindred contained similar EREDITARY spherocytosis (HS) is a common hemo-H lytic anemia characterized by the presence of spherocytes and increased erythrocyte osmotic fragility.' The disease is usually inherited in an autosomal dominant pattern but apparently recessive variants occur. The primary defect is believed to reside in the erythrocyte membrane skeleton, a network of proteins underlying the lipid bilayer, including spectrin, actin, ankyrin, band 3 (AEI, the red blood cell [RBC] anion exchange protein), and proteins 4.1 and 4.2. ' HS RBCs from both variants are usually spectrin defi~i e n t~.~ and the degree of deficiency correlates well with the spheroidicity of HS erythrocyte^^-^ and the response of patients to splenectomy: In a subset of patients with severe recessive HS, the primary defect probably resides in a-spectrin. Many of these patients have a mutation in the or41 domain,&* although it is not clear whether this is the cause of HS or simply a linked polymorphism. In contrast, in dominant HS spectrin, defects have only been identified in patients in three unrelated families, all of whom are heterozygous for an unstable P-spectrin that lacks the ability to bind protein 4.1 and, as a consequence, binds poorly to actin.','" In one well-studied instance,'&I2 spectrin Kissimmee, there is a single amino acid change in a conserved region near the N-terminus of P-spectrin," fl 202T'p+Aq, which probably forms part of the 4.1 binding site."
H lytic anemia characterized by the presence of spherocytes and increased erythrocyte osmotic fragility.' The disease is usually inherited in an autosomal dominant pattern but apparently recessive variants occur. The primary defect is believed to reside in the erythrocyte membrane skeleton, a network of proteins underlying the lipid bilayer, including spectrin, actin, ankyrin, band 3 (AEI, the red blood cell [RBC] anion exchange protein), and proteins 4.1 and 4.2. ' HS RBCs from both variants are usually spectrin defi~i e n t~.~ and the degree of deficiency correlates well with the spheroidicity of HS erythrocyte^^-^ and the response of patients to splenectomy: In a subset of patients with severe recessive HS, the primary defect probably resides in a-spectrin. Many of these patients have a mutation in the or41 domain,&* although it is not clear whether this is the cause of HS or simply a linked polymorphism. In contrast, in dominant HS spectrin, defects have only been identified in patients in three unrelated families, all of whom are heterozygous for an unstable P-spectrin that lacks the ability to bind protein 4.1 and, as a consequence, binds poorly to actin.','" In one well-studied instance,'&I2 spectrin Kissimmee, there is a single amino acid change in a conserved region near the N-terminus of P-spectrin," fl 202T'p+Aq, which probably forms part of the 4.1 binding site."
Recently, ankyrin defects have been reported in some HS kindreds. First, two unrelated patients with unusually severe, morphologically atypical HS and combined deficiencies of spectrin and ankyrin were described by Coetzer et aLL4 Studies of one ofthese patients suggest that the primary defect is in ankyrin, which is synthesized, but is unstable and is degraded before it is assembled on the membrane." Second, rare patients with HS, psychomotor retardation, growth failure, hypogonadism, and combined spectrin-ankyrin deficiency are heterozygous for an interstitial deleon the short arm of chromosome 8 that involves the erythroid ankyrin gene at 8p I 1.1 and surrounding DNA.'' Other rare families with balanced translocations that break at 8p 1 1.1 (and presumably involve the ankyrin locus) have tion16-19 amounts of spectrin and ankyrin ( 2 3% to 4%). Spectrin and ankyrin levels were almost always less than the assay controls, but were less thari the normal range in only 75% and 80% of kindreds, respectively. Remarkably, the degree of RBC spectrin and ankyrin deficiency was very similar in 19 of 20 HS kindreds. One otherwise typical family differed, with marked ankyrin deficiency (45% of control) and a relatively mild spectrin deficit (81 %). We conclude that most patients with dominant HS have combined ankyrin and spectrin deficiency and that the two proteins are usually about equally deficient, suggesting that defects in ankyrin expression, ankyrin stability, or ankyrin band 3 (AEI ) interactions may be common in dominant HS. typical dominant HS without associated retardation or gonadal Third, ankyrin has been genetically linked to spherocytosis in one large family with typical, mild, dominant HS23 and two other HS families with combined spectrin-ankyrin deficiency have been r e~o g n i z e d .~~ Finally, a shortened form of ankyrin (ankyrin Prague) has been identified in one dominant HS family. '5 These recent findings suggest that ankyrin defects may be a common underlying feature of HS, especially among patients with the dominant form ofthe disease. The purpose of the present study was to determine what proportion ofdominant HS patients are ankyrin deficient and whether there is a relationship between spectrin and ankyrin deficiencies.
MATERIALS AND METHODS

Subjects.
Thirty-nine patients from 20 unrelated families with typical autosomal dominant HS were included in the study. Each of them fulfilled certain criteria, ie, a peripheral blood smear showed 225% spherocytes and no other significant morphologic abnormality, incubated osmotic fragility was increased, a Coombs test was negative, and there was a clear pattern of dominant inheritance. Healthy volunteer donors were used as controls.
Blood samples were collected in EDTA, washed three times in phosphate-buffered saline to remove the buffy coat, and diluted to Preparation of antibodies. Polyclonal antispectrin antibodies (nos. 8000 and 8412) were raised in rabbits against a mixture of native and SDS-denatured a-and P-spectrin. They stained both spectrin subunits in immunoblots of human RBC ghosts (1:2,000 to 1:5,000 dilution) and did not react with purified ankyrin. Polyclonal rabbit antiankyrin antibodies (nos. 7000,7608, and 7609) were developed using a mixture of native and SDS-denatured ankyrin and its 62-kD spectnn binding fragment. Antisera nos. 7608 and 7609 are high titer antisera and are effective at dilutions of 1:50,000 to 1:100,000. At a dilution of 1:40,000 they detect ankyrin (band 2. I, 206 kD) and numerous ankyrin subspecies (ankyrins 2. RIAs. The spectrin and ankyrin contents of RBCs were determined using the competitive RIA described by Agre et al' with some modifications. In general, protein A-bearing staphylococci were precoated with spectrin or ankyrin antibodies" and mixed with iodinated spectrin or an iodinated fragment of ankyrin, the 62-kD spectrin binding domain. The number of counts bound under these conditions was taken as 100%. The assay was then standardized with increasing amounts of unlabeled spectrin or 62-kD ankyrin, which progressively displaced the radioactive protein.
A similar displacement approach was used to measure the spectrin or ankyrin present in SDS-solubilized RBCs. The 62-kD fragment of ankyrin was used because whole ankyrin is more difficult to purify, tends to aggregate on storage, and is more sensitive to proteolysis.
To prepare the immunoadsorbent, protein A-bearing staphylococci (IgGsorb; The Enzyme Center, Malden, MA) were washed in 6 vol of 100 mmol/L NaCI, 20 mmol/L Na phosphate, 1 mmol/L EDTA, and 0.1% (vol/vol) Triton X-100, pH 7.5 (buffer A); resuspended in buffer A at a concentration of 10% (vol/vol); incubated with 0.5 vol of undiluted antiserum at room temperature for 30 minutes; rewashed three times with buffer A; and stored for up to 3 weeks at 4°C as a 10% suspension in buffer A plus 0.05% NaN,.
Before the assay, the RBCs and all of the proteins, both labeled and unlabeled, were separately incubated at 60°C in 1 % (wt/vol) SDS in phosphate-buffered saline for I O minutes and then diluted 240-fold into RIA buffer ( 1 50 mmol/L NaCI, IO mmol/L Na phosphate, I mmol/L EDTA, 1 mmol/L NaN,, I% [vol/vol] Triton X-100, 1 mg/mL bovine serum albumin, pH 7.9.'
The assay was performed in triplicate in 12-X 75-mm polystyrene tubes containing 0.8 mL of RIA buffer, 50,000 cpm of 1251-labeled spectrin or 12SI-labeled 62-kD ankyrin, varying dilutions of unlabeled proteins or RBC lysate, and a 0.3% (vol/vol) suspension of antibody-labeled staphylococci (diluted 1:9 with washed, unlabeled staphylococci so that only about 40% ofthe added cpm precipitated before the addition of unlabeled proteins or RBC lysate). The samples were shaken vigorously at 4°C for 16 hours (spectrin) or 40 hours (ankyrin) and then washed twice with 4 mL of buffer B (2 mol/L urea, I% [vol/vol] Triton X-100, 0.1 mol/L glycine) and counted. Linear regression and other statistics were analyzed with the Statgraphics computer programs (Statistical Graphics Corp, Rockville, MD).
Erythrocyte membranes were analyzed by SDS-PAGE, using the Fairbanks buffer system" and 3.5% to 17% nonlinear gradient slab gels.' The gels were stained with Coomassie blue, and the bands corresponding to spectrin, ankyrin, band 3 (AE I), actin, and proteins 4.1 and 4.2 were excised. The dye was eluted with 25% pyridine and quantified spectrophotometrically (605 nm).33 Five to eight replicates of each sample were run to average out variations in the resolution and excision of the gel bands. Five to eight replicates of a control sample were also included on each gel. The raw protein data from each replicate were normalized to a constant amount of band 3 (to correct for variations in protein loading), averaged, and expressed as a percentage of the assay control (to correct for gel to gel variations in staining).
SDS gel electrophoresis.
RESULTS
Quantitation of ankyrin and spectrin in normal
RBCs. Typical results ofthe ankyrin RIA are shown in the left panel of Fig 1. The displacement curves for 62-kD ankyrin and RBCs are parallel, which indicates that the ankyrin antiserum detects the same epitopes in the protein standard and solubilized cells. Under these conditions, the ankyrin content of an average RBC can be determined from the numbers of ankyrin molecules and RBCs that displace 50% of the labeled ankyrin fragments. Normal RBCs contain an average of 124,500 * 11,000 (SD, n = 26) ankyrin molecules (Fig 1, right panel) , which is similar to previous estimate^.^^,^' This measurement presumably includes all forms of ankyrin (ankyrin bands 2. I , 2.2, 2.3,2.6, etc) that are detected by the ankyrin antiserum.
In the spectrin RIA, the displacement curves for the standard and RBCs are also parallel (Fig 2, left panel) . Normal RBCs contain 242,000 20,500 (SD, n = 22) spectrin heterodimers per cell (Fig 2, right panel) . This is also close to previous estimate^.^,^.^' RBC ankyrin and spectrin were also measured in 39 patients from 20 unrelated families with typical dominant HS. The results for each patient and the mean values for families containing more than one affected member are summarized in Fig 3A  (ankyrin) and B (spectrin). Measurements in the same patient on different occasions (n = 18) averaged 29.0% for ankyrin and k5.490 for spectrin.
Most families had ankyrin-deficient RBCs, as the mean value of the kindreds was less than the simultaneous control in 19 of 20 families and was less than the lower limit of normal (-2 SD, 432%) in 16 families (80%). The distribu-
Ankyrin andspectrin content ofHS RBCs.
For (Fig 3A) . ranging from 4 I % to 105% of simultaneous controls, and appeared to be continuous, which suggests there are many causes for ankyrin deficiency in these families or that other variables affect ankyrin expression. In contrast. affected members of a kindred only differed. on average. by 3.5% from the mean ankyrin value of the kindred. which was much less than the variation between kindreds. Spectrin content of HS RBCs was also reduced, consistent with previous observation^."^ The mean value of RBC spectrin for a kindred was less than the simultaneously run control in all 20 families and was below the lower limit of controls (-2 SD, 584%) in 15 (75%). Individual spectrin levels ranged from 46% to 102% of simultaneous controls and. similar to ankyrin, varied much less within families than between families (Fig 3B) . Remarkably, levels of ankyrin and spectrin were highly correlated in 19 ofthe 20 families(Fig4.0). Within experimental error. the degree of spectrin and ankyrin deficiencies was essentially identical in these families, with one exception Relutionskip q/' ankyrin and spmrin deficiencies. To test whether the balanced deficit of spectrin and ankyrin in dominant HS was simply due to physical loss of membrane fragments. we determined the content of other membrane skeletal proteins by SDS gel electrophoresis in 4 unrelated dominant HS patients. The results. expressed as the ratio of each protein to band 3 (AEI), were spectrin/ band 3 = 79% -C 7% (% of control f SD). ankyrinlband 3 = 8 1% f 4%. 4. I /band 3 = I0270 -C 16%. 4.2/band 3 = 94% f 6%. and actinfband 3 = 97% f 24%. The data. although limited, indicate that the deficiency of spectrin and ankyrin is selective. It is unlikely that simple membrane fragmentation would produce this result.
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DISCUSSION
This study shows that balanced, combined deficiency of erythrocyte spectrin and ankyrin is a common feature of dominant HS. It was present in at least 70% (14 of 20) ofthe kindreds we examined (Fig 4) . One family showed predominate ankyrin deficiency (family 8). Spectrin and ankyrin levels were less than simultaneous controls in 4 of the other 5 kindreds, but the degree of deficiency did not exceed the normal range. Some of these families are probably also spectnn-ankyrin deficient, but this is impossible to prove without a more precise assay.
The fact that HS RBCs are spectnn deficient is well known from the pioneering work of Agre et a1,3.4 but the frequency of ankyrin deficiency was not previously known.
In retrospect, early observations of Hill et and Sawyer et aI3' hinted that problems in spectrin-ankyrin interactions might exist in HS. They observed slower and less complete dissociation of spectrin and actin from ghosts or membrane skeletons and a 40% reduction in the binding of a crude spectrin extract to spectrin-depleted membranes. The reduction was caused by the loss of spectrin binding sites rather than a decrease in bindingaffinity. However, the studies were performed with crude protein extracts and seemed to be contradictory. Moreover, direct measurements of spectrin rebinding to spectrin-depleted HS membranes were normal in two independent l a b o r a t~r i e s .~~'~*~* This was probably caused by inherent limitations of the binding assay, which can vary by as much as 50%, even in practised hands. The degree of ankynn deficiency observed in this study vanes from 0% to 60% (median, 22%) and is mild enough in most patients that it would be difficult to detect in a typical spectrin binding assay.
It is only recently that autosomal dominant HS has been associated with defects of erythroid ankyrin (Ank 1).'43'5,'9,23,24 The initial reports dealt with patients who had unusually severe HS and atypical RBC morphology associated with unstable ankyrin14.'' or who had a syndrome of HS, psychomotor retardation, growth failure, and hypogonadism associated with heterozygous deletion of the ankyrin locus (at 8p 1 I. I ) and neighboring portions of chromosome 8.19 More recent studies have focused on typical dominant HS. In one large family, ankyrin was genetically linked to HS using a restriction fragment p~lymorphism.'~ Members of this kindred have mild hemolysis and mild spectrin deficiency (e 15%). RBC ankyrin was not measured, but, judging from SDS gels, it is normal or only For personal use only. on September 24, 2017. by guest www.bloodjournal.org From mildly decreased (P. Agre, personal communication). In another kindred, reported in preliminary form,24 affected individuals have a small ankyrin isoform (ankyrin Prague, 174 kD) that probably lacks a portion of the regulatory domain. Finally, rare families with typical dominant HS have balanced translocations that break at 8pl l . l and presumably involve the ankyrin locus.2@22
These reports, together with the present observations, are compatible with the hypothesis that ankyrin deficiency is the primary defect in the majority ofthe patients with dominant HS and that spectrin deficiency is secondary to the loss of ankyrin attachment sites.
The opposite view, that spectrin deficiency is primary (eg, caused by diminished spectrin synthesis or damage to the spectrin-ankyrin interaction) and fosters loss of the uncovered ankyrin, is not supported by known examples. Mice with complete or nearly complete spectrin deficiency and severe spherocytosis caused by homozygous defects at the a-spectrin (sph, sphhe, sphZJ, and sphZBc mutations) or pspectrin (iu mutation) loci have roughly normal amounts of RBC ankyrin on SDS as do humans with recessive HS and marked spectrin defi~iency.~' Combined deficiency could result from decreased synthesis of ankyrin or band 3 or from impaired interaction of the two proteins. The wide variation in the degree of spectrinankyrin deficiency from kindred io kindred suggests there are many different mutations. However, the fact that spectrin and ankyrin are equally deficient in most kindreds suggests that these mutations may be qualitatively similar.
Two examples of decreased ankyrin synthesis are known. Ankyrin and spectrin are deficient in both conditions, but ankyrin deficiency predominates. For example, RBCs from a patient who is heterozygous for a deletion of the erythroid ankyrin locus (ANK1) contain 59% of the normal amount of ankyrin, 79% of the normal amount of spectrin, 74% of the normal amount of protein 4.2, and normal amounts of protein 4.1 and actin." Similarly, mice that are homozygous for the nb mutation and lack erythrocyte ankyrin39p40,42 have reduced but not absent levels of RBC spectrin (~5 0 % of n~r m a l~~.~~) .
In both cases the actual numbers are probably about 20% lower than stated since the skeletal proteins were quantified relative to the amount of band 3; some band 3 is lost along with membrane lipids and other integral membrane proteins in spherocytes? Nevertheless, it is surprising that spectrin levels exceed ankyrin because ankyrin is thought to be the sole high-affinity spectrin-binding protein in mature R B C S .~~ Perhaps some spectrin binds via protein 4.1 or actin. Alternatively, membrane proteins may exist early in erythroid development that have some affinity for erythroid spectrin, particularly when RBC ankyrin is deficient. Brain ankyrin (Ank2), which can bind erythrocyte ~p e c t r i n ,~~ is present in mouse fetal liver cells,45 which are mostly erythroid, and it (or other ankyrins) might also be expressed in adult marrow erythroblasts. In addition, nonankyrin proteins that bind spectrins to membranes are and could exist in developing erythroid cells. Once bound, spectrin would establish lateral connections to other membrane proteins and tend to remain attached despite the absence of Ank 1.
Examples of primary band 3 (AE1) deficiency may also exist. In about 10% to 15% of dominant HS patients, erythrocytes contain 25% to 40% less band 3 than n~r m a l .~' "~ Band 3 synthesis is normal49 but the molecule is lost progressively as the cells circulate,"' particularly the "mobile" band 3 fraction.49 This fraction represents band 3 that is not bound to the skeleton, which suggests that the primary defect may affect self-association of band 3 rather than its interactions with ankyrin or other skeletal proteins. In support of this, we have quantified membrane proteins in three affected members of one band 3-deficient family4' (RBC band 3 = 75% of normal), using both SDS gels and radioimmunoassays, and find normal levels of spectrin, ankyrin, actin, and proteins 4.1 and 4.2 (Savvides et al, unpublished observations) . If the results are representative, band 3 deficiency could not be responsible for HS in the majority ofthe patients in our survey, although it could be present in the families with normal or near normal levels of RBC spectrin and ankyrin (Fig 4) . We spent many months attempting to develop a radioimmunoassay for band 3 to explore this possibility; however, none of our antibodies were satisfactory. The displacement curves produced by solubilized RBCs and the band 3 standard (the 43-kD cytoplasmic domain) were always nonparallel, which indicates that the antibodies detected different epitopes in the two preparations.
The phenotype of ankyrin-band 3 binding defects is unknown. An apparent defect in the ankyrin-band 3 interaction, associated with severe hemolysis and poikilocytosis, was described some years but subsequent investigations showed these patients also had a defect in spectrin self-association. Theoretically, defects in ankyrin that alter band 3 binding could lead to balanced spectrin-ankyrin deficiency if RBC membranes self-assemble, as predicted by Lazarides.52 Lazarides suggests that newly synthesized membrane skeletal proteins such as spectrin and ankyrin spontaneously associate in the cytoplasm, as they do in vit r~,~~ and the prefabricated parts coalesce into a mature skeleton when band 3 is expressed, relatively late in erythroid differentiation. Failure of preformed spectrin-ankyrin complexes to bind to band 3 would lead to loss of both components. In contrast, simple absence of ankyrin might allow spectrin to bind to lower affinity sites, as noted earlier, and paradoxically lead to less severe spectrin deficiency.
Unfortunately, ankyrin-band 3 binding is difficult to measure in vitro, so it will not be easy to test for a functional defect in HS patients, particularly if binding is only decreased by 20% to 40%, as seems likely. It will not be easy to screen for ankyrin-band 3 binding defects by molecular methods either, because large portions of both molecules will have to be tested. The band 3 binding site in ankyrin is localized to the C-terminal halfofthe 89-kD domain, particularly the last two ankyrin repeats53; however, the 55-kD "regulatory" domaid4 influences band 3 binding55s56 and could also be defective. The ankyrin binding site in band 3 involves widely scattered portions of the cytoplasmic doFor personal use only. on September 24, 2017. by guest www.bloodjournal.org From main57,58 that are probably brought together when the domain folds.
In principle, our patients could also have a defect of protein 4.2, because it binds to both ankyrin and band 359 and may help strengthen their interaction.60 However, this is not likely. Humans who lack protein 4.2 sometimes have a mild form of HS,60-63 but, with one exception,63 the disease is inherited as an autosomal recessive and is not detectable in the heterozygous ~t a t e .~~,~' ,~~ Moreover, RBC spectrin and ankyrin are not deficient, even when 4.2 is a b~e n t .~~.~' ,~~ Finally, it is important to add a comment regarding methodology. As noted by Agre et al,4 RIAs are more accurate than SDS gels for quantitating RBC spectnn, in part because band 3 is lost with other membrane surface components as spherocytes circulate, which causes spectrin (expressed as a spectrin/band 3 ratio) to be overestimated. This is even more true for ankyrin, which is present in smaller amounts and lies close to P-spectrin on SDS gels. If optimal conditions are used, reproducible and reasonably accurate results can be obtained when ankyrin deficiency is moderate (>30%).19 These conditions include the use of exponential gradient Fairbanks gels, multiple replicates, saturation staining of bands, and quantitation by dye elution and spectrophotometry. Gradient Fairbanks gels' are needed to optimize the separation of spectrin and ankyrin. Laemmli gels are unsatisfactory because ankyrin lies between the spectrin bands in the Laemmli gel system. The dye elution techn i q~e~~ is important, especially compared with densitometry, because it is easy to adjust the dye concentration so that one remains within the linear portion of a Beer's Law plot.
However, even when SDS gels are performed under optimal conditions, the spectrin and ankyrin RIAs are more accurate and less work, particularly when multiple samples are analyzed. Unfortunately, quantitation of spectrin and ankyrin in HS RBCs is arduous no matter what technique is used, because very small deficits must be measured. Better methods are needed if spectrin or ankyrin measurements are to become routine. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
